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Abstract- One of the great challenges in the treatment of infectious diseases is the resistance of 
pathogenic bacteria against antibiotics, and antibiotic resistance to Shigella is broadly observed in 
different parts of the world. The object of this study was to determine Shigella antibiotic resistance 
pattern against the antibiotics such as ampicillin, amoxicillin, trimethoprim–sulfamethoxazole, 
chloramphenicol, nalidixic acid, ciprofloxacin and ceftriaxone. In this cross-sectional study, a total of 
147 Shigella strains were collected from the diarrheic patients referring to different medical centers of 
Zahedan. Specific antisera were used for serotyping of isolated Shigella and their antibiotic resistance 
patterns were determined by standard Kirby-Bauer method. Of the 147 studied Shigella strains, 102 
(69.3%) belonged to S. flexneri, 32 (21.7 %) to S. dysenteriae, 11 (7.4%) to S. boydii, and 2 (1.36%) to 
S. sonnei species. The isolated strains showed resistance to ampicillin (99.3%), trimethoprim-
sulfamethoxazole (52%) and nalidixic acid (1.3%), but there was no resistance against ciprofloxacin 
and ceftriaxone. According to the findings, it is suggested that antibiotics should not be used without 
laboratory testing (antibiogram).  
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INTRODUCTION 
 
Shigellosis is an acute gastroenteritis which is one of 
the most common causes of morbidity and mortality 
in children with diarrhea in developing countries. It 
is caused by microorganisms belonging to the genus 
Shigella. The annual number of Shigella episodes 
throughout the world is estimated to be 164.7 million, 
with 69% of all deaths attributable to shigellosis 
involving  children  less than 5 years old (1).  
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The disease is highly contagious due to its low 
infectious dose (2). Epidemics usually occur in areas 
with crowding and poor sanitary conditions (3-6). 
Essential events in the pathogenesis of Shigella 
infections include bacterial invasion of epithelial 
cells, escape from the phagosome, and induction of 
apoptosis in macrophages (7). Shigellosis is caused 
by any of the four species of Shigella, namely, 
Shigella dysenteriae, S. flexneri, S. boydii, and S. 
sonnei. Except for S. sonnei, each species contains 
multiple serotypes, based on the structure of the O 
antigen (8). 
More than 140 million cases of Shigellosis are 
reported annually worldwide and it is responsible for 
death of 6 million children under the age of 5, 
especially in developing countries. The symptoms of 
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Shigellosis might be mild to serious and apart from 
general and intestinal symptoms, there may be other 
complications such as hemolytic uremic syndrome. 
In this syndrome, 50% of the patients suffer from 
serious kidney dysfunction and 5 to 10% of them 
expire (9). 
The epidemiology and antibiotic susceptibility of 
shigella species change. Antibiotic resistance is seen 
as increasing or decreasing in this concern (10). 
Therefore antibiotic resistance pattern of Shigella 
must be determined to assist the doctors to choose 
the suitable antibiotics.  
The present study was done to determine the drug 
resistance pattern of Shigella species in Zahedan, 
south-east of Iran.  
 
MATERIALS AND METHODS 
 
In this cross-sectional study, 147 Shigella strains 
were isolated from patients with bloody diarrhea in 
Zahedan during 2003-2004. The study was approved 
by Ethics Committee of Zahedan University of 
Medical Sciences. 
The specimens were cultured on differential and 
selective media including XLD agar and SS agar. 
After 48 hours incubation in 37º C, biochemical tests 
were used to confirm the bacteria including growth 
on TSI agar, SIM, Simmons citrate and MR-VP 
reaction and etc. (11).  
Specific antisera (Difco Shigella Antiserum) 
were used for serotyping of isolated Shigella. The 
susceptibilities of all isolates to different antibiotics 
were determined by the disk diffusion method, using 
amoxicillin, trimethoprim-sulfamethoxazole, ampicillin, 
chloramphenicol, nalidixic acid, ciprofloxacin and 
ceftriaxone (Bio Merieux Anti. Disk)  
 
RESULTS 
 
Results revealed that from 147 studied Shigella 
strains, 102 strains belonged to S. flexneri (69.4%),  
32 strains to S. dysenteriae (21.8%), 11 strains to  S. 
boydii (7.5%) and 2 strains to S. sonnei (1.3%) 
species (Table 1).  
Resistance pattern against the applied antibiotics 
were as follows: ampicillin (99.3%), trimethoprim- 
sulfamethoxazole (57.1%),  chloramphenicol  (52%), 
Table 1. The frequency of Shigella spp. isolated from 
diarrheic patients in Zahedan in 2003-2004 
% Frequency Shigella type 
69.4 102 S. Flexneri 
21.8 32 S. Dysenteriae 
7.5 11 S. Boydii 
1.3 2 S. Sonnei 
100.0 147 Total 
 
nalidixic acid (1.3%) and there was no resistance to 
ciprofloxacin and ceftriaxone (Table 2). The 
frequency distribution of these resistant strains was 
as follows: S. flexneri 71%, S. dysenteriae 18.4%, S. 
boydii 10.5%. S. sonnei resistance against these 
antibiotics was negligible. 
 
DISCUSSION 
 
The frequency of different species of Shigella varies 
in different countries. The most abundant species of 
Shigella in present study was S. flexneri which is 
similar to studies in Japan (12, 13), Ethiopia (14), 
India (15, 16), Senegal (17), Spain (18), Pakistan 
(19) and Kuwait (20). On the other hand, the most 
prevalent Shigella species in Australia (21) Poland 
(22), Turkey (10) and Saudi Arabia (23) have been 
S. sonnei. In our study, the least isolation was for S. 
sonnei (1.3%) which is similar to Ethiopia (14). 
Results of studies in Poland (24) and Australia 
(21) have shown variations in prevalence of different 
species of Shigella in different parts of a single 
country (21, 24). In Lekehno, India, S. sonnei (4.6%) 
was the least reported species whilst in another city 
of India, Calcutta, S. boydii (9%) was reported as the 
least common species (15). In the latter study, most 
abundant species was S. flexneri whilst in former 
study S. dysenteriae was the most abundant    
species.  
 
Table 2. The frequency of resistance pattern of Shigella spp. 
isolated from diarrheic patients in Zahedan in 2003-2004 
%FrequencyAntibiotic
99.3 146 Ampicillin 
57.1 84 Trimethoprim-Sulfamethoxazole 
52 76 Chloramphenicol 
1.3 19 Nalidixic acid 
0 0 Ciprofloxacin 
0 0 Ceftriaxone 
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In the present study highest rate of resistance was 
observed against ampicillin (99.3%). This is similar 
to results of a study in Senegal in which all the 
isolated bacteria showed resistance to this antibiotic 
(17). Resistance rate to ampicillin in Kuwait, 
Turkey, Pakistan, Ethiopia and India has been 
reported as  54%, 72.9%, 55.5%, 70.1% and 69%, 
respectively (20, 10, 19, 14, 15). It is clear that 
application of this antibiotic is not appropriate. The 
result of a study in Fiji Island also emphasizes this 
finding (24).  
After ampicillin, the highest resistance rate in our 
study was against trimethoprim-sulfamethoxazole 
(58.1%). In Ethiopia 5.3%, in Kuwait 56%, in 
Turkey 70%, and in Pakistan 87.75% of Shigella 
strains were resistant to trimethoprim-
sulfamethoxazole (14, 20, 10, 19). Resistance rate 
has been reported to be more than 90% in India, and 
the effectiveness of this antibiotic in the treatment of 
shigellosis is reported to be reducing (15). In Poland 
only two Shigella species have reported as sensitive 
to this antibiotic (22). Therefore, it is suggested that 
application of trimethoprim-sulfamethoxazole must 
be confirmed by antibiogram. It seems that 
resistance to this antibiotic is correlated with the 
isolated species because the frequency of the 
resistance in S. flexneri has been about 50% whereas 
it has been more than 65% in S. dysenteriae and S. 
boydii. These differences emphasize the necessity to 
determine the species before clinical usage of 
antibiotics.  
The least resistance in our study was against 
nalidixic acid (1.3%). In Senegal (17), India (25) and 
Poland (21), no resistance reported against this 
antibiotic whereas in Saudi Arabia 46.1% (23), 
Pakistan 39% (19), Vietnam 3.5% (26), Ethiopia 
6.5% (14), Calcutta 29% (15) and southern India 
94% (25) of the isolated bacteria were resistant to 
this antibiotic. In Japan resistance to this antibiotic 
has increased from 13.3% to 50% within a period of 
7 years (12, 13). In Japan, more than half of the 
resistant strains are isolated from traveler diarrhea (27).  
In our study, no resistance observed against 
ciprofloxacin and ceftriaxone. In similar studies in 
Vietnam and Kuwait there were also no resistance to 
ciprofloxacin (26, 20), and in Fiji Island these two 
antibiotics were reported effective for the treatment 
of Shigellosis, although the treatment cost were 
reported more than the other applied antibiotics (24). 
In Calcutta, 4% of the isolated Shigella strains had 
moderate sensitivity to ciprofloxacin, indicating 
appearance of antibiotic resistant strains in India. It 
seems that S. sonnei isolation is increasing and its 
resistance to antibiotics such as ciprofloxacin and 
nalidixic acid is notable in India (15). 
One of the problems in treatment is the 
appearance of multiple drug resistant strains. In the 
present study, 25.8% of studied strains had resistant 
to ampicillin, trimethoprim-sulfamethoxazole and 
chloramphenicol.  High resistance was observed to 
ampicillin, chloramphenicol and trimethoprim-
sulfamethoxazole in Ethiopia (14). The comparison 
between the results of the present study with 
Ethiopian study shows that the frequency of the 
resistance, especially against ampicillin, 
trimethoprim-sulfamethoxazole and chloramphenicol, 
has been increased.   
In the light of findings of our study, we strongly 
recommend that antibiotics should not be used 
without laboratory testing (antibiogram). More 
research is needed in this area and other antibiotics 
must be evaluated. 
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